Nitric Oxide in Retinal and Choroidal Blood Flow Autoregulation in Newborn Pigs: Interactions with Prostaglandins
- 1 March 1996
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 39 (3) , 487-493
- https://doi.org/10.1203/00006450-199603000-00017
Abstract
The role of nitric oxide (NO) as well as its interaction with prostaglandins (PG) in setting the limits of autoregulation of retinal blood flow (RBF) and choroidal blood flow (ChBF) were studied in newborn pigs (1-5 d old). Blood flows were measured by the microsphere technique. Low and high ocular perfusion pressures (OPP) were induced by inflating balloon-tipped catheters placed at the aortic root and isthmus, respectively. Animals were treated with the NO synthase inhibitors, NG-nitro-L-arginine methyl ester (L-NAME, 1 mg/kg followed by 50 μg/kg/min; n = 12) or NG-monomethyl-L-arginine (L-NMMA, same dose as L-NAME;n = 3), or with saline (n = 12). In separate animals(n = 42), guanosine 3′,5′-cyclic monophosphate (cGMP), the second messenger for NO, and PG were measured at an average OPP of 90 mm Hg and 125 ± 6 mm Hg; cGMP levels served as an index of NO release. The effect of the NO donor sodium nitroprusside on choroidal vessel diameter was determined using video imaging of isolated eyecup preparations. In control animals RBF was constant only within a range of 30 to 80 mm Hg OPP(r = 0.03, p > 0.9). There was no autoregulation of ChBF which increased as a function of OPP (τ = 0.58-0.72, p < 0.01). L-NAME and L-NMMA prevented a change in RBF and ChBF from 30 to 146 mm Hg [the highest OPP studied (r < 0.3, p > 0.15)] and caused an increase in retinal as well as choroidal vascular resistance as OPP was raised; these agents did not affect ocular blood flow at OPP < 30 mm Hg. Elevated OPP caused increases in cGMP, 6-keto-PGF1α, and PGE2 in the choroid (a vascular tissue), which were prevented by L-NAME and L-NMMA. Sodium nitroprusside caused a dilatation of choroidal vessels in isolated eyecup preparations, which was significantly attenuated by indomethacin. Data suggest a role for NO in the autoregulation of RBF and ChBF in the newborn such that a release of NO during a rise in OPP prevents adequate constriction necessary for maintaining RBF and ChBF constant; data also suggest that the vasodilator effect of NO might in part be mediated through a release of PG.Keywords
This publication has 22 references indexed in Scilit:
- Metabolite utilization and compartmentation in porcine carotid artery: a study using beta-guanidinopropionic acidAmerican Journal of Physiology-Cell Physiology, 1995
- Nitric oxide activates cyclooxygenase enzymes.Proceedings of the National Academy of Sciences, 1993
- NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists.Circulation Research, 1993
- Nitric oxide modulates coronary autoregulation in the guinea pig.Circulation Research, 1992
- A Cohort Study of Transcutaneous Oxygen Tension and the Incidence and Severity of Retinopathy of PrematurityNew England Journal of Medicine, 1992
- Physiological release of nitric oxide is dependent on the level of vascular toneEuropean Journal of Pharmacology, 1990
- Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure. Cerebral blood flow autoregulation of the newborn.Circulation Research, 1990
- Cerebral autoregulation dynamics in humans.Stroke, 1989
- Biochemical Mechanisms Underlying Vascular Smooth Muscle RelaxationJournal of Cardiovascular Pharmacology, 1988
- The Oxygen Supply to the Retina, II. Effects of High Intraocular Pressure and of Increased Arterial Carbon Dioxide Tension on Uveal and Retinal Blood Flow in CatsActa Physiologica Scandinavica, 1972